Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus
Apr 26, 2018•36 min
Episode description
In 2010, John McCutcheon joined Ceterix, a start-up with big goals and a surer FDA path than his previous company. McCutcheon recounts the FDA's battering of that company, Emphasys, and explains how his current company is rolling today.
For the best experience, listen in Metacast app for iOS or Android
